China Isotope & Radiation Corporation (HKG:1763)
Hong Kong · Delayed Price · Currency is HKD 19.34
+1.24 (6.85%)
Apr 20, 2026, 4:08 PM HKT
China Isotope & Radiation Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,188 | 7,575 | 6,635 | 6,154 | 5,144 | |
Revenue Growth (YoY) | -5.11% | 14.16% | 7.82% | 19.63% | 20.34% |
Cost of Revenue | 3,566 | 3,892 | 3,153 | 2,636 | 1,902 |
Gross Profit | 3,622 | 3,683 | 3,482 | 3,518 | 3,242 |
Selling, General & Admin | 2,330 | 2,329 | 2,406 | 2,365 | 2,320 |
Research & Development | 301.92 | 300.29 | 306.05 | 300.51 | 196.21 |
Other Operating Expenses | -74.25 | -72.24 | -50.33 | -53.81 | -28.36 |
Operating Expenses | 2,602 | 2,603 | 2,733 | 2,643 | 2,499 |
Operating Income | 1,019 | 1,080 | 749.68 | 874.88 | 742.85 |
Interest Expense | -64.05 | -47.21 | -34.83 | -33.66 | -34.04 |
Interest & Investment Income | 37.38 | 34.09 | 36.57 | 51.69 | 30.99 |
Earnings From Equity Investments | 16.55 | 7.27 | 16.98 | 42.17 | 60.66 |
Currency Exchange Gain (Loss) | -7.82 | -9.44 | -4.39 | -13.29 | -1.65 |
Other Non Operating Income (Expenses) | -5.83 | - | - | - | - |
EBT Excluding Unusual Items | 995.51 | 1,065 | 764.01 | 921.78 | 798.81 |
Gain (Loss) on Sale of Investments | -0.8 | -19.34 | - | - | 4.55 |
Gain (Loss) on Sale of Assets | 9.56 | -0.2 | 158.42 | -1.12 | -0.68 |
Asset Writedown | -0.22 | - | - | - | - |
Other Unusual Items | 0.08 | 0.16 | - | 0.13 | - |
Pretax Income | 1,004 | 1,045 | 922.44 | 920.79 | 802.68 |
Income Tax Expense | 339.58 | 165.69 | 146.31 | 165.56 | 129.64 |
Earnings From Continuing Operations | 664.54 | 879.54 | 776.13 | 755.24 | 673.04 |
Minority Interest in Earnings | -337.12 | -472.89 | -405.16 | -362.96 | -337.29 |
Net Income | 327.43 | 406.65 | 370.97 | 392.28 | 335.75 |
Net Income to Common | 327.43 | 406.65 | 370.97 | 392.28 | 335.75 |
Net Income Growth | -19.48% | 9.62% | -5.43% | 16.84% | 57.20% |
Shares Outstanding (Basic) | 320 | 320 | 320 | 320 | 320 |
Shares Outstanding (Diluted) | 320 | 320 | 320 | 320 | 320 |
EPS (Basic) | 1.02 | 1.27 | 1.16 | 1.23 | 1.05 |
EPS (Diluted) | 1.02 | 1.27 | 1.16 | 1.23 | 1.05 |
EPS Growth | -19.48% | 9.62% | -5.43% | 16.84% | 57.20% |
Free Cash Flow | - | -889.71 | -812.66 | 286.74 | 366.59 |
Free Cash Flow Per Share | - | -2.78 | -2.54 | 0.90 | 1.15 |
Dividend Per Share | 0.307 | 0.381 | 0.313 | 0.441 | 0.378 |
Dividend Growth | -19.48% | 21.81% | -28.95% | 16.62% | 109.59% |
Gross Margin | 50.39% | 48.62% | 52.48% | 57.16% | 63.03% |
Operating Margin | 14.18% | 14.26% | 11.30% | 14.22% | 14.44% |
Profit Margin | 4.55% | 5.37% | 5.59% | 6.38% | 6.53% |
Free Cash Flow Margin | - | -11.75% | -12.25% | 4.66% | 7.13% |
EBITDA | 1,225 | 1,286 | 972.91 | 1,058 | 901.43 |
EBITDA Margin | 17.04% | 16.97% | 14.66% | 17.19% | 17.52% |
D&A For EBITDA | 205.76 | 205.76 | 223.23 | 182.76 | 158.58 |
EBIT | 1,019 | 1,080 | 749.68 | 874.88 | 742.85 |
EBIT Margin | 14.18% | 14.26% | 11.30% | 14.22% | 14.44% |
Effective Tax Rate | 33.82% | 15.85% | 15.86% | 17.98% | 16.15% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.